Re: Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties (Toxicol. Appl. Pharmacol. 232, 351-358, 2008).
Dorandeu
Frederic
F
Carpentier
Pierre
P
Dhote
Franck
F
Mion
Georges
G
Baille
Valerie
V
Testylier
Guy
G
Lallement
Guy
G
D000818:Animals; D001285:Atropine / Q000627:therapeutic use; D001925:Brain Damage, Chronic / Q000139:chemically induced / Q000517:prevention & control; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004338:Drug Combinations; D004827:Epilepsy / Q000139:chemically induced* / Q000517:prevention & control; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006168:Guinea Pigs; D006801:Humans; D007649:Ketamine / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010755:Organophosphates / Q000633:toxicity*
D018680:Cholinergic Antagonists; D004338:Drug Combinations; D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D010755:Organophosphates; D007649:Ketamine; D001285:Atropine